Product NewsDrug discovery > Clinical Development to-BBB Presents Clinical Data on Lead Product 2B3-101
Application NoteEstablishment of KRAS G12C mutant brain metastasis models for preclinical evaluation of KRAS G12C targeted anti-cancer therapy
